Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Franco-Nevada Corporation (FNV) vs Philip Morris International Inc. (PM) Price & Performance

Franco-Nevada CorporationTrade
Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

Franco-Nevada Corporation vs Philip Morris International Inc. — how do they compare? Franco-Nevada Corporation trades at $233.84 (market cap $46.80B), while Philip Morris International Inc. trades at $207.2 (market cap $310.62B). The key difference: Philip Morris International Inc. is far larger — about 6.6× Franco-Nevada Corporation's market cap, and Philip Morris International Inc. pays the higher dividend (3.21%). Which is the better fit depends on your goals — on Pluang, investors hold Franco-Nevada Corporation for 0 Days and Philip Morris International Inc. for 85 Days on average.

FNVPM
Market Cap
$46.80B$310.62B
Volume
310,6924,145,126
Sector
Basic MaterialsConsumer Staples
52-Week High
$280.82$205.58
52-Week Low
$183.97$144.33
Typical Hold Time
0 Days85 Days
Enterprise Value
$45.79B$353.73B
Dividend Yield
0.72%3.21%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Franco-Nevada Corporation

Franco-Nevada (FNV) trades at $243.85, showing a slight decline of 0.77% over the past day. The stock is positioned neutrally from a technical perspective, with key support near $242 and resistance at $246. Fundamentally, the company exhibits strong profitability with a net income margin of 63.79% and has beaten earnings expectations in two of the last three quarters. Recent news highlights portfolio expansion, including a significant investment in the Bullabulling Gold Project and positive developments regarding the potential restart of the Cobre Panama mine.

The outlook for FNV is supported by analyst consensus, with a price target of $275 suggesting potential upside. Key opportunities include revenue growth from new projects and high profit margins. Risks involve execution on new investments, commodity price volatility, and geopolitical factors affecting mining operations. The balanced analyst rating split indicates cautious optimism for future performance.

Philip Morris International Inc.

Philip Morris International (PM) trades at $202.00, up 0.4% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $212.17. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.20, and maintains robust profitability with a net income margin of 25.56%. Recent news highlights growth in smoke-free products like IQOS and ZYN, now over 40% of revenue, and a raised 2026 EPS forecast due to favorable currency impacts.

The stock offers a compelling growth story driven by smoke-free product expansion and dividend reliability, but faces risks from regulatory pressures and high valuation multiples. With 68% of analysts rating it a Buy, upside exists toward the $225 high target, though investors should monitor debt levels and industry shifts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FNV
100% Buy0% Sell
Avg holding period · 0 Days
PM
32% Buy68% Sell
Avg holding period · 85 Days

Top news

Latest headlines on both assets

About Franco-Nevada Corporation

Franco-Nevada Corporation is a royalty and streaming company that finances mining and energy projects in exchange for royalty payments or the right to purchase output at set prices, holding a diversified portfolio across Precious Metals, Other Mining, and Energy (oil, gas, and natural gas liquids).

Read more on FNV →

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Read more on PM →